Tag: License
Revvity signs new license agreement with AstraZeneca for Next-Gen Base Editing...
Non-exclusive agreement provides AstraZeneca access to proprietary gene editing technology to help advance its work in cell therapy
Sun Pharma & AstraZeneca enter into license agreement for novel oncology...
As per the terms of the agreement, Sun Pharma will be responsible for development, regulatory filings and manufacturing the products covered in the agreement while AstraZeneca will exclusively promote and distribute these products in China...................
CSIR-IGIB seeks interest from industry to commercialize key technologies
The Institute of Genomics and Integrative Biology (IGIB) has invited an expression of interest from industries who want to either license the technology or partner with it in co-development leading to commercialization.....
USFDA accepts Mylan & Biocon’s proposed biosimilar Pegfilgrastim for review
The development marks the second successful biologics license application (BLA) for filing of the partnership in the United States of America...
US-FDA accepts Mylan & Biocon’s joint application on biosimilar Trastuzumab
While the Biologics License Application (BLA) for MYL-1401O has been accepted by the United States FDA, if approved, it has the potential to be the first biosimilar Trastuzumab in the US....
Anti diabetic drug, Ayush-82 to hit the market soon
This ayurvedic formulation for management of diabetes developed by Central Council for Research in Ayurvedic Sciences...